Lipopolysaccharide activates NF-κB p65 to transcribe Mettl3 and Mettl14, boosting Tgf-β1 mRNA m6A modification in the 5'-UTR for cap-independent translation and NAFLD progression22. Here, METTL3 is linked to metabolic dysfunction-associated steatotic liver disease.